Defer Decisions On Generic Drugs: IMA 

Hyderabad, Aug 14 (Hydnow): The Indian Medical Association (IMA) headquarters today has urged the Union Government to defer the implementation of National Medical Commission (NMC) regulation on generic drugs and hold wider consultations on the vital topic with stakeholders before taking a final decision.

“The biggest impediment to generic drugs is the uncertainty about their quality, as there is practically no guarantee of the quality of such drugs.  Less than 0.1 percent of the drugs that are manufactured in India are tested for quality. Prescribing generic drugs without quality would be detrimental to patients.

The decision on generic drugs should be deferred till the government can assure the quality of all the drugs released into the market.  Patient care and safety are not negotiable.  “IMA demands a foolproof system of quality assurance before switching over to generic drugs.  Only good quality drugs should be made available in the country and prices should be uniform and affordable.  We urge the Government to have a ‘one drug, one quality, one price’ system whereby all brands should be either sold at the same price which should be controlled or banned, and only generics allowed while ensuring the highest quality of these drugs. (Hydnow) 

Next story :

Now you can get the latest stories from Hydnow every day. Click the link to subscribe. Click to follow Hydnow’s Facebook page and Twitter and Instagram